Download PDF
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2023; 06(01): 017-024
DOI: 10.1055/s-0043-176327
Original Article

Thyroxine Replacement Therapy during Ramadan Fasting: Physicians' and Patients' Perceptions and Practices

Salem A. Beshyah 
1   Department of Medicine, Yas Clinic Khalifa City, Khalifa City, Abu Dhabi, United Arab Emirates
2   Department of Medicine, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
3   Department of Medicine, Dubai Medical College for Girls, Dubai, United Arab Emirates
,
Aly B. Khalil 
4   Imperial College London Diabetes Center, Abu Dhabi, United Arab Emirates
,
Anas S. Beshyah
5   Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
,
Mahmoud M. Benbarka
5   Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
,
Ibrahim H. Sherif
5   Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
› Author Affiliations Funding and Sponsorship None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective Thyroxine (T4) therapy is taken on an empty stomach and no food is taken for a short period. During Ramadan fasting (RF), Muslim patients may face difficulties taking levothyroxine as recommended.

Materials and Methods We performed a mixed methods study of an online survey of 218 physicians to explore their perceptions and practices. Also, we interviewed a sample of 172 hypothyroid patients to establish their practices and source of information. Their median age was 46 (17–90) years; they had hypothyroidism for a median of 5 years and took a median thyroxine dose of 100 µg daily. Furthermore, we attempted to explore the effects of RF on available thyroid function tests.

Results Consultants were 58.4%, and the most represented specialty was endocrinology, 46.1%. Regarding the impact of RF on T4 therapy, 52.3% thought the RF was not clinically relevant in most patients on T4 replacement. However, 27.5% thought RF affects T4 replacement therapy in a clinically relevant manner. About 77.1% of respondents reported giving advice routinely to all patients on T4 replacement during RF. One hundred sixty-four respondents were split between recommending taking the medications with Iftar, Suhour, or other times. Most respondents (73.9%) do not repeat measurements of thyroid hormone levels after Ramadan unless needed during their scheduled clinic visit. On the other hand, 50.3% of the patients confirmed that their physician advised them to take their thyroxine during Ramadan, whereas 40.4% could not recall receiving any advice. About 59.9% of the patients took thyroxine with Iftar, 23.8% with Suhour, and 16.3% at different times. In those patients where thyroid function tests were available before and after RF, serum thyroid-stimulating hormone and serum-free T4 did not show a specific pattern in the group as a whole and with subgroups.

Conclusion There is variation in the advice that hypothyroid patients receive on taking thyroxine during Ramadan and in their practices. Further studies are needed to determine the best timing for thyroxine replacement.

Keywords

hypothyroidism - thyroxine replacement therapy - Ramadan fasting - Patients' perceptions - Physicians' practices

Authors' Contributions

S.A.B. adapted the questionnaire and managed the online and patients survey. A.S.B. managed the data collection and analysis. All other authors reviewed the data and contributed to the data analysis and interpretation, drafting, and revising the manuscript and approving its final version.


Compliance with Ethical Principles

The physician survey was approved by the IRB of Sheikh Khalifa Medical City, and all physicians provided informed consent digitally before they could answer the survey questions. The patient section was conducted as a quality improvement exercise; patients provided informed verbal consent for their data to be included in the audit. All data were analyzed anonymously.




Publication History

Article published online:
03 March 2023

© 2023. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Biondi B, Cooper DS. Thyroid hormone therapy for hypothyroidism. Endocrine 2019; 66 (01) 18-26
    CrossrefPubMedGoogle Scholar
  • 2 Colucci P, Yue CS, Ducharme M, Benvenga S. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol 2013; 9 (01) 40-47
    CrossrefPubMedGoogle Scholar
  • 3 Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab 2009; 94 (10) 3905-3912
    CrossrefPubMedGoogle Scholar
  • 4 Bhutani S, Bhutani J, Balhara YP, Kalra S. Atypical thyroxine replacement in hypothyroidism: a clinical audit. Thyroid Res Pract. 2012; 9: 81-83
    CrossrefGoogle Scholar
  • 5 Rajput R, Chatterjee S, Rajput M. Can levothyroxine be taken as evening dose? comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism. J Thyroid Res 2011; 2011: 505239 DOI: 10.4061/2011/505239.
    CrossrefPubMedGoogle Scholar
  • 6 Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med 2010; 170 (22) 1996-2003
    CrossrefPubMedGoogle Scholar
  • 7 Roky R, Houti I, Moussamih S, Qotbi S, Aadil N. Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab 2004; 48 (04) 296-303
    CrossrefPubMedGoogle Scholar
  • 8 Beshyah SA, Fathalla W, Saleh A. et al. Ramadan fasting and the medical patient: an overview for clinicians. Ibnosina J Med Biomed Sci. 2010; 2 (05) 240-257
    Article in Thieme ConnectGoogle Scholar
  • 9 Hadjzadeh M, Pakdel R, Hayatdavoudi P, Nematy M. Hypothyroidism and Ramadan fasting. J Fasting Health 2014; 2: 80-83
    Google Scholar
  • 10 Beshyah SA, Fiad TM, Saadi HF. Management of common endocrine conditions other than diabetes mellitus during Ramadan fasting. Ibnosina J Med BS 2012; 4 (04) 137-146
    Article in Thieme ConnectGoogle Scholar
  • 11 Karoli R, Fatima J, Chandra A, Mishra PP. Levothyroxine replacement and Ramadan fasting. Indian J Endocrinol Metab 2013; 17 (02) 318-319
    CrossrefPubMedGoogle Scholar
  • 12 Raza SA, Ishtiaq O, Unnikrishnan AG. et al. Thyroid diseases and Ramadan. Indian J Endocrinol Metab 2012; 16 (04) 522-524
    CrossrefPubMedGoogle Scholar
  • 13 Beshyah SA, Ali KF. Management of adrenal insufficiency: a survey of perceptions and practices of physicians from the Middle East and North Africa. J Diabetes Endocr Pract 2021; 4: 125-130
    Article in Thieme ConnectGoogle Scholar
  • 14 Beshyah SA, Khalil AB. Clinical practice patterns in the management of thyroid nodules: the first survey from the Middle East and Africa. J Diabetes Endocr Pract 2021; 4: 167-174
    Article in Thieme ConnectGoogle Scholar
  • 15 Beshyah SA, Almalki MH, Azzoug S, Barake M, Al Dahmani K, Chihaoui M. Diagnosis and management of Cushing's disease: a survey of endocrinologists from the Middle East and North Africa. J Diabetes Endocr Pract 2022; 5: 21-28
    Article in Thieme ConnectGoogle Scholar
  • 16 Al-Qahtani KM, Aldeeri IA, Alshaibi AM. et al. Optimal timing of thyroid hormone replacement during Ramadan fasting: a randomized controlled trial in patients with prior total thyroidectomy. Thyroid 2022; 32 (09) 1029-1036
    CrossrefPubMedGoogle Scholar
  • 17 Alkaf B, Siddiqui M, Ali T. et al. Ramadan fasting and changes in thyroid function in hypothyroidism: identifying patients at risk. Thyroid 2022; 32 (04) 368-375
    CrossrefPubMedGoogle Scholar
  • 18 Dellal FD, Ogmen B, Ozdemir D. et al. Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment. J Coll Physicians Surg Pak 2020; 30 (10) 1009-1014
    CrossrefPubMedGoogle Scholar
  • 19 El-Kaissi S, AbdelWareth L, Dajani R. et al. Levothyroxine administration during Ramadan: a prospective randomized controlled trial. Eur Thyroid J 2021; 10 (06) 455-460
    CrossrefPubMedGoogle Scholar
  • 20 El-Kaissi S, Dajani R, Lee-St John TJ. et al. Impact of lifestyle changes during Ramadan on thyroid function tests in hypothyroid patients taking levothyroxine. Endocr Pract 2020; 26 (07) 748-753
    CrossrefPubMedGoogle Scholar
  • 21 Elsherbiny TM. Impact of fasting on thyrotropin and thyroid status during Ramadan in 292 previously well controlled hypothyroid patients. IFTAR study. Endocrine 2023; 79 (03) 484-490
    CrossrefPubMedGoogle Scholar
  • 22 Or Koca A, Dağdeviren M, Altay M. Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?. Turk J Med Sci 2020; 50 (04) 784-788
    CrossrefPubMedGoogle Scholar
  • 23 Sheikh A, Mawani M, Mahar SA. Impact of Ramadan fasting on thyroid status and quality of life in patients with primary hypothyroidism: a prospective cohort study from Karachi, Pakistan. Endocr Pract 2018; 24 (10) 882-888
    CrossrefPubMedGoogle Scholar
  • 24 Zaboon IA, Alidrisi HA, Hussein IH. et al. Best time for levothyroxine intake in Ramadan (THYRAM): Basrah experience. Int J Endocrinol Metab 2020; 18 (02) e94325
    CrossrefPubMedGoogle Scholar